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Abstract
High intraindividual performance variability is one of the most robust findings to emerge in cognitive-experimental research
of attention deficit hyperactivity disorder (ADHD). Evidences from studies incorporating structural or functional human brain
mapping methods indicate that this increased intraindividual variability is not simply a sequel of general brain dysfunction,
but is likely related to the functioning of neural circuits that engage the prefrontal cortex, particularly the dorsolateral areas
(dlPFC). In order to examine further the anatomical and pharmacological substrate responsible for this high intraindividual
variability disorder, we injected GABAA antagonist (bicuculline) or GABAA agonist (muscimol) in the dlPFC of monkeys
performing a reflexive oculomotor task. Here we show that, whereas GABAA agonist injection induced no or minimal
impairments, injection of GABAA antagonist dramatically increased the intraindividual variability of saccade response time
and of saccade spatial accuracy (amplitude and direction). Overall, this study demonstrates that the balance between
excitatory/inhibitory activities in the dlPFC is fragile but crucial, since local micro-injection of GABAA antagonist can induce
marked behavioural effects. It also reveals that higher cognitive areas such as the dlPFC are markedly capable to influence
the productions and metrics of reflexive movements. Altogether, this study provides promising perspectives for the
development of new therapeutic strategies for the treatment of diseases in which high intravariability disorders are a
prominent feature.
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Introduction
Significant and reliable differences in the speed and the
variability of responses have been documented between ADHD
and typically developing children (TDC) across a wide variety of
neuropsychological tasks [1,2]. Increased variability, that is
hypothesized to reflect underlying unstable attentional resources,
is seen in tasks requiring continual responses to rapid stimuli as
well as basic reaction time (RT) tasks [3]. Children with ADHD
display are often found to respond more slowly and less accurately
than the typically developing peers. However and importantly,
response variability correlates more strongly and reliably with
ratings of ADHD symptoms than commission errors or other
outcome measures [4]. Evidences from studies incorporating
structural or functional human brain mapping methods indicate
that this intraindividual variability may not simply be a sequel of
general brain dysfunction, but may likely be related to the
functioning of neural circuits that, among other brain areas,
engage the prefrontal cortex, particularly the dorsolateral areas
(dlPFC) [5,6–14]. In order to examine further the anatomical and
pharmacological substrate of this high intraindividual variability
disorder, we injected a GABAA antagonist (bicuculline) or a
GABAA agonist (muscimol) in the dlPFC of monkeys performing a
reflexive oculomotor task (see supplementary information). Here,
we show that specific and focal perturbation of GABA-mediated
circuit in the dlPFC is capable to generate high intraindividual
performance variability.
Results
As shown in Figure 1, in a representative injected site within the
dlPFC, the variability of simple RTs dramatically increased after
GABAA antagonist injection (Figure 1A), but not after GABAA
agonist injection (Figure 1B). This result was confirmed across all
injected sites (100%; 15/15 and 11/11sites; respectively 9 and 6
for monkey A and 6 and 5 for monkey B). Statistically and
compared to pre-injection periods, GABAA antagonist but not
GABAA agonist injections significantly increased RT variability
(Figure 2A and 2B) (U(15,11)=152, p,0.001; and U(15,11)=11,
p.0.05). Similar effects were observed when complete control
experiments or saline injections were compared to GABAA
injections (see Text S1). This effect was bilateral in both monkeys
(see Figure S2 and Text S1). Injection of GABAA antagonist did
also affect important metric properties of the movements, since
variability of both saccade gain and direction were markedly
affected (see Text S1 and Figure S3, S4). Specificity of dlPFC
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injections in the supplementary eye fields and Pre-SMA (Figure
S6). For both SEF and Pre-SMA, the variability in response times
did not significantly vary following GABAA agonist or antagonist
(p&0.5).
Two methods were used to further examine the sequences of
collected RTs. First, distinct serial correlations of RTs were
calculated for each experimental block of trials (preceding or
following the micro-injection of GABAA antagonist, GABAA
agonist or saline). The correlations were then averaged across
sessions and monkeys. Figure 3 shows the average serial
correlations obtained for GABAA antagonist, GABAA agonist
and saline injections at lags of up to 15 trials. Across monkeys and
injection sites, the serial correlations obtained after GABAA
antagonist injections is lower than GABAA agonist injections at
lags up to 6 trials (U(15,11)=336, p=.03 ). These results are
consistent with the noticeable noise observed following GABAA
antagonist injection as shown in Figure 1.
Then, a series of Lomb-Scargle periodograms were calculated
for the different subsequences of trials following the injections. The
resultant power spectra were averaged across monkeys and
sessions. Similar to what has been reported previously in the
literature, the power of RTs oscillations following injection of
GABAA agonist is centered in the lowest part of frequencies
Figure 1. Response time sequences. (A) Response time sequences
in simple pro-saccade task following GABAA antagonist (bicuculline)
injection. These sequences were taken from 4 consecutive blocks of
trials for monkey A. (B) Same convention as A when GABAA agonist was
injected in the same site. Note the marked increased scatter of both
parameters after bicuculline injection, with interleaved normal and
markedly impaired values. Each dot corresponds to a saccade. Empty
dots: pre-injection trials. Filled dots: post-injection trials.
doi:10.1371/journal.pone.0005208.g001
Figure 2. Comparison of GABAA antagonist (bicuculline) and
GABAA agonist (muscimol) injections on response times
variability (ms). Note the marked effect of GABAA agonist injections
and the null effect of GABAA agonist on the variability of simple
response times.
doi:10.1371/journal.pone.0005208.g002
Figure 3. Serial correlations between response times (RTs).
Average of correlations for 16 sites of monkeys A and B. The different
correlations estimated from sequences preceding (thin line) or
following injections (thick line) of GABAA agonist (blue line) and
antagonist (orange line) are plotted separately. The correlations
between RTs and past RTs are presented at lags up to 15 trials.
doi:10.1371/journal.pone.0005208.g003
Frontal Cortex and Variability
PLoS ONE | www.plosone.org 2 April 2009 | Volume 4 | Issue 4 | e5208spectrum (Figure 4) c. In contrast, the power of RTs oscillations
following the GABAA antagonist injections are more similar to
white noise power spectrum traduced by an overall increase the
power spectrum distribution (Figure 4). Again, these results are
consistent with the noticeable noise and the smaller lag observed in
serial correlations for GABAA antagonist sequences as shown in
Figures 1 and 3 (see also Figure S5). Functionally, the presence of
white noise within the sequences of RTs following GABAA
antagonist injections is also consistent with the view that these
sequences were generated by a more unstable and more chaotic
process in which short or long term memory are less or not
expressed.
Discussion
It is well established that simply instructing human or non-
human primate subjects to focus attention is not sufficient to
prevent them from distractibility [1,2]. In the primate brain, the
dlPFC is a frontal cortical region known to be engaged in these
attentional, memory and high level executive functions [15,16].
Our results show here that focal pharmacological perturbations of
the dlPFC are also capable to impair a basic motor task with a low
cognitive load [15–17]. These results are important for at least two
reasons. First, they indicate that the classical boundaries
delimitating the highest cognitive processes and the levels of
motor encoding stages is less tight than previously thought.
Second, these results open a novel route to explore long-term
pharmacological treatments for the numerous patients suffering
from attentional disorders.
In human, recent studies comparing TDC with ADHD
children has shown increased of intraindividual variability at all
parts of the spectrum of RTs, even in tasks with the lowest
cognitive loads [1,2,10]. These measures of variability appeared
to be so robust that intraindividual variability in RTs is now
viewed as a valid endophenotype with the potential ability to
index genetic vulnerability to ADHD reflecting attentional
lapses on some but not all responses [2]. Before these recent
findings, poorer performances in neuropsychological tasks of
ADHD children were typically interpreted as evidence for high
level executive function deficits. This interpretation was
partially supported by the fact that ADHD children produce
on average slower and less accurate responses than TDC.
However, it has subsequently been shown that intraindividual
variability of these RT sequences often correlates better with the
behavioural symptoms of ADHD than the mean values.
Consistent with the possibility that the dlPFC is implicated in
t h ep a t h o l o g yo fA D H D ,w es h o wh e r et h a tm i n i m a ll o c a l
micro-injections of GABAA antagonist but not GABAA agonist
in the dlPFC exert a profound effect on intraindividual
variability during sequences of a simple response task. This
variability was observed in the RTs as well as the direction and
the amplitude of the movement.
In our study, only Bicuculline (GABAA antagonist) affected the
monkey’s behavior. This result may be considered as circum-
stantial to our simple response task but is not trivial. In V1,
micro-injection of GABAA antagonist (bicuculline) was found to
exert a much weaker effect on neuronal responses compared to
GABAA agonist (muscimol) [18]. However, and importantly, it
was noticed that both administrations of GABAA antogonist and
GABAA agonist in visual cortex resulted in improved visual
function [19,20]. In other subcortical and cortical regions
implicated in visual target selection and saccade programming,
it has been shown that the application of GABAA (bicuculline)
greatly facilitates saccade production, whereas injection of
GABAA agonist (muscimol) inhibits saccade generation [18–
21]. The increased intrasubject variability observed in the
present study appears therefore to be specifically related to
dlPFC dysfunction. Altogether these results let us speculate that,
rather than the absolute activity of the GABA-mediated circuits
in dlPFC, what might be more crucial to the behavioural
expression depends on the fragile balance between activation or
inhibition of the GABA-mediated circuits. Depending on the
task, on the environmental constraints and/or the level of
activity of other GABAergic circuits, a modest variation can lead
to dramatic behavioural changes. In our experiment, using a
simple saccadic reflexive task, a GABAA antagonist action
appeared to be the solely route to affect the balance and the
subsequent behaviour.
The reaction time variability is one of the strongest findings
that recently emerge in cognitive-experimental research on
ADHD. However, it is important to notice that the symptoms of
ADHD are heterogeneous and often accompanied by multiple
comorbid psychiatric disorders. If our finding among others offer
a new route for potential pharmacotherapies capable to
influence the activity of GABAA receptors, further researches
would be needed in order to understand better the principles and
rules that govern the variations of the most simple of our
behavioural responses.
Materials and Methods
Two adult male green monkeys (Caercopitheca aethiops) were
used. The maintenance of the monkeys, all surgical procedures
and the experimental protocols were carried out in strict
accordance with the National Institutes of Health (NIH)
guidelines (1996) and the recommendations of the EEC (86/
609) and the French National Committee (87/848). Before
training, each monkey underwent a surgical procedure for the
implantation of a scleral search coil on each eye and an acrylic
head holder. At the end of the training period, a recording
chamber was implanted above the principal sulcus (PS), on each
side. Heart rate and body temperature were monitored during
Figure 4. Log–log plot of average Lomb–Scargill power
spectrum estimates, for response times sequences following
GABAA agonist (blue line) and GABAA agonist (orange line)
injections. Frequency f is cycles-per-block.
doi:10.1371/journal.pone.0005208.g004
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following days.
Behavioural tasks
Monkeys were trained to look at a central green fixation
stimulus for 700–1,200 msec. After a 200 ms blank period (gap), a
2 deg62 deg green target appeared 16 degrees from the fixation
target at one of six possible radial locations (0u,4 5 u, 135u, 180u,
225u, or 315u), during 1,000 ms. After the saccade, the monkey
received a reward if the saccade fell within a 5u65u window
centered on the target. Failure to enter a 3u63u window around
the fixation stimulus or to trigger a saccade within 2000 ms after
target onset cancelled the trial. Each task consisted in blocks of 24
trials each in which each radial location was presented semi-
randomly. Eye movements were recorded with the search coil
technique, as described previously [10].
Localization of the principal sulcus
The Figure S1 shows the injected sites. The PS was localized
by electrophysiological recordings performed with tungsten
microelectrodes (FHC, 8–9 MV at 1 kHz). Electrical stimula-
tion (80 ms of biphasic pulses at 350 Hz, current up to 150 mA)
was used to delineate the frontal eye field and confirmed that
no saccade could be elicited from the posterior sites of this
area.
Localization of SEF and pre-SMA. In a third control case,
injections were made in the SEF and in the pre-SMA. The SEF
and pre-SMA were classically localized by electrophysiological
recordings performed with tungsten microelectrodes (FHC, 8–
9M V measured at 1 kHz). Electrical stimulation (80 ms of
biphasic pulses at 350 Hz, current up to 150 mA) was used to
delineate SEF and confirmed by elicitation of saccade with current
as low as 50 mA. The pre-SMA was delineated centro-caudal from
the posterior sites of SEF area and rostral to the orofacial region of
the SMA.
Micro-injection procedure
Bicuculline, a GABAA antagonist, or muscimol (Sigma), a
GABAA agonist, were injected through a 30-gauge stainless steel
cannula lowered into the brain with a transdural guide tube. Once
the tip of the cannula was at the desired level, 2.5 ml of bicuculline
(5 mg/ml) or 4 ml of muscimol (5 mg/ml) were injected with a 10 ml
Hamilton syringe during 16 minutes. In monkey A, 10 sites were
injected with bicuculline, four of them being injected with
muscimol. In monkey B, bicuculline was injected at 6 sites, all
these sites being also injected with muscimol.
Data analysis
Saccades were identified offline and controlled visually. In
each experiment, we analyzed primary saccade latency, gain
and direction. Saccade gain was defined as the ratio of primary
saccade amplitude and target eccentricity. Saccade direction
was determined in degrees (positive values: from 0u to 180u
counterclockwise, negative values: from 0u to 180u clockwise).
For each saccade, we determined its directional accuracy by
calculating a directional error in degrees. Thus, a +5u
directional error corresponds to a saccade with a slightly
counterclockwise deviated direction. The directional error was
obtained by subtracting saccade direction from target direction,
i.e. the ideal vector that would have been required to acquire
the target.
Statistical analyses
Differences between groups were assessed using the rank sum
test, also referred as Mann-Whitney test (Matlab2008b, Math-
works). This test was used so that the normality of the populations
was not assumed. Level of significance was set to p=0.05.
Correlations were calculated using Spearman rank order test.
Supporting Information
Text S1
Found at: doi:10.1371/journal.pone.0005208.s001 (0.02 MB
DOC)
Figure S1 Injection sites. (A) Injection sites in the region of dlPFC
for monkey A. Orange dots represent sites at which GABAA
antagonist (bicuculline) was injected. Blue circled dot represent sites
at which GABAA agonist (muscimol) was injected. PS: principal
sulcus. AS: arcuate sulcus. (B) Same conventions for monkey B.
Found at: doi:10.1371/journal.pone.0005208.s002 (0.65 MB
DOC)
Figure S2 Variability of response time. (A) Variability of
response times as function of experimental session types for
monkey A When the eye movement is produced ipsilaterally (full
line box) or contralaterally (dotted line box) to the injection site.
Blue circled dots represent sites at which both bicuculline and
muscimol were injected. (B) Same conventions for monkey B.
Found at: doi:10.1371/journal.pone.0005208.s003 (0.37 MB
DOC)
Figure S3 Variability of saccade amplitude gain as function of
experimental and control sessions types. Grey background areas
correspond to pre-injection sessions; white background areas to
post-injection sessions.
Found at: doi:10.1371/journal.pone.0005208.s004 (0.26 MB
DOC)
Figure S4 Variability of relative saccade direction as a function
of the experimental and control session type. Grey background
areas correspond to pre-injection sessions; white background areas
to post-injection sessions.
Found at: doi:10.1371/journal.pone.0005208.s005 (0.26 MB
DOC)
Figure S5 Log-log plot. (A) Log-log plot of average Lomb-
Scargill power spectrum estimates, for response times sequences
following GABAA agonist (thick orange line) and GABAA agonist
(thin blue line) injections for Monkey A. Frequency f is cycles-per-
block. (B) Same convention for monkey B.
Found at: doi:10.1371/journal.pone.0005208.s006 (0.91 MB
DOC)
Figure S6 Variability of response time. (A) Variability of
response times as function of experimental session types for
monkey C after injection in the right SEF. When the eye
movement is produced ipsilaterally (full line box) or contralaterally
(dotted line box) to the injection site. (B) same convention as A
after injection in the left SEF. (C) same convention as A and B
after injection in the Pre-SMA.
Found at: doi:10.1371/journal.pone.0005208.s007 (0.39 MB
DOC)
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